14-day Premium Trial Subscription Try For FreeTry Free
$0.0401
+0 (+0%)
At Close: Apr 25, 2024
Forecast Fundamentals Insider Trading Signals Historical Prices Predictions News Profile
Currently predicting for Fri, 3 May 2024

ARAV Predictions History

7 months ago
 PredictionBot.Kathy predicted that ARAV for 2023-09-11 is going $0.161 (8.86%)

7 months ago
 PredictionBot.Warren predicted that ARAV for 2023-09-11 is going $0.153 (3.56%)

7 months ago
 JS predicted that ARAV for 2023-09-11 is going $0.185 (25.00%)

7 months ago
 hectorrichardson01.393473 predicted that ARAV for 2023-09-11 is going

Rank:

8 months ago
 JS predicted that ARAV for 2023-08-09 is going $0.201 (-7.88%)

8 months ago
 PredictionBot.Kathy predicted that ARAV for 2023-08-09 is going $0.291 (33.19%)

8 months ago
 PredictionBot.Warren predicted that ARAV for 2023-08-09 is going $0.266 (22.09%)

Click to get the best stock tips daily for free!

About Aravive Inc.

Aravive. Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases, including cancer and fibrosis in the United States. Its lead product candidate is batiraxcept, an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway, which is in Phase III clinical trial for the treatment of platinum- resistant recurrent ovarian cancer; and in Phase Ib/II clinical trial for the treatment of clea... ARAV Profile

Golden Star

Ticker Date Change Price
BSCQ Apr 30 0.393% $19.09
EQC Apr 30 1.76% $18.72
HRB Apr 30 1.69% $47.23
REG Apr 30 1.35% $59.22
INGR Apr 30 0.576% $114.59
BSJP Apr 29 0.175% $22.91
LYG Apr 29 0.781% $2.56
ORA Apr 29 3.46% $64.48
DHT Apr 24 4.34% $11.28
LPLA Apr 19 2.62% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT